Spruce Biosciences Inc. (Nasdaq: SPRB) jumped to $ 175.00 during the trade after the hours on Monday, an increase of 34.20% or $ 44.60 compared to the final race. View the current price of SPRB shares here. During regular trading hours, SPRB increased $ 121.58, which marked a profit of 1,378.46% and according to Benzinga […]
Aptevo Therapeutics Inc APVO The shares rise on Wednesday. According to data from Benzinga Pro, the share is higher with a strong volume of 81.8 million compared to the average volume of 275.3k. What happened: Aptevo revealed new clinical data from the current phase 1b/2 Rainier study for evaluation of mipletamig, the first-in-class CD123 x […]
GT Biopharma, Inc. GTBP announced on Monday that it successfully completed the dosage in cohort 1 and started dosing in cohort 2 of his phase 1 dose of escalation study for GTB-3650. The therapy is a trike-therapeutic targeting of the second generation, refunded or refractory CD33-to expression hematological malignancies. GT Biopharma specializes in immuno-oncology therapies […]